Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Regadenoson
Drug ID BADD_D01921
Description Regadenoson is an A2A adenosine receptor agonist that causes coronary vasodilation and used for myocardial perfusion imagining. Manufactured by Astellas and FDA approved April 10, 2008.
Indications and Usage Diagnostic agent for radionuclide myocardial perfusion imaging (MPI)
Marketing Status approved; investigational
ATC Code C01EB21
DrugBank ID DB06213
KEGG ID D05711
MeSH ID C430916
PubChem ID 219024
TTD Drug ID D0XE1C
NDC Product Code 55150-443; 0409-1401; 76329-3321; 42973-229; 76055-0024; 60505-6116; 72611-874; 59285-029; 69766-103; 68083-175; 16729-477; 71288-201; 0641-6253; 65129-1331; 43598-616; 0469-6501; 62147-0220; 36000-364
UNII 2XLN4Y044H
Synonyms regadenoson | Lexiscan | CVT 3146 | CVT3146 | CVT-3146
Chemical Information
Molecular Formula C15H18N8O5
CAS Registry Number 313348-27-5
SMILES CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.0010.001852%Not Available
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.0030.000829%
Acute myocardial infarction24.04.04.001; 02.02.02.0010.000169%Not Available
Acute pulmonary oedema22.01.03.005; 02.05.02.0040.000085%Not Available
Altered state of consciousness19.07.01.003; 17.02.04.001--Not Available
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angina pectoris24.04.04.002; 02.02.02.002--
Angioedema23.04.01.001; 10.01.05.009; 22.04.02.008--Not Available
Anxiety19.06.02.002--
Aphasia19.21.01.001; 17.02.03.0010.000499%
Apnoea22.02.01.0010.000085%
Arthralgia15.01.02.001--
Asthenia08.01.01.001--Not Available
Asthma10.01.03.010; 22.03.01.002--Not Available
Atrial fibrillation02.03.03.002--
Atrial flutter02.03.03.003--
Atrioventricular block02.03.01.0020.000651%Not Available
Atrioventricular block complete02.03.01.0030.000482%
Atrioventricular block first degree02.03.01.0040.000169%
Atrioventricular block second degree02.03.01.0050.000524%
Back pain15.03.04.0050.001192%
Blood pressure diastolic decreased13.14.03.003--Not Available
Blood pressure systolic decreased13.14.03.007--Not Available
Bradycardia02.03.02.0020.001057%Not Available
Bronchospasm22.03.01.004; 10.01.03.0120.000296%
Bundle branch block left02.03.01.0070.000085%Not Available
Burning sensation08.01.09.029; 17.02.06.0010.001480%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 7 Pages